COVID-19-related complications – Page 2 – Communicable Diseases Research

Role of Inflammatory Cytokines in COVID-19 Patients: A Review on Molecular Mechanisms, Immune Functions, Immunopathology and Immunomodulatory Drugs to Counter Cytokine Storm

Review

Published on 2021-04-292022-10-28
Journal: Vaccines [Category] COVID-19,

High Levels of Common Cold Coronavirus Antibodies in Convalescent Plasma Are Associated With Improved Survival in COVID-19 Patients

회복기 혈장에서 높은 수준의 일반적인 감기 코로나바이러스 항체는 COVID-19 환자의 생존율 향상과 관련이 있습니다

Clinical Trial

Published on 2021-04-282022-08-13
Journal: Frontiers in Immunology [Category] MERS, SARS, 임상, 진단,

[키워드] Administered age Anderson Cancer Center anti-HCoV-HKU1 spike IgG anti-HCoV-OC43 anti-HCoV-OC43 spike IgG anti-SARS-CoV-2 antibodies antibody antibody levels Antigen antigens association Bayesian Bayesian exponential survival time regression model Cancer patients CCP CCP administration Cold common common cold convalescent plasma coronavirus coronavirus antibodies coronavirus strains COVID-19 COVID-19 convalescent plasma COVID-19 infection COVID-19-related complications died domain early stage effective Factor female HCoV-HKU1 HCoV-OC43 HKU1 Hospitalized identify IgG antibodies Improved Level MD Anderson Cancer Center median age moderate moderate to severe monoclonal antibody non-SARS-CoV-2-specific antibodies OC43 Other other coronaviruses outcomes Patient PBE PBEs posterior probability prognostic variable prognostic variables quantified Regression model Result Safe SARS-CoV-2 SARS-CoV-2-specific antibody Severe COVID-19 Infection Sex specific antibodies specific antibody spike IgG survival survival time the disease therapeutic target
[DOI] 10.3389/fimmu.2021.675679 PMC 바로가기 [Article Type] Clinical Trial

Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID-19: Design and rationale for the DARE-19 study

COVID-19로 인한 호흡 부전 환자의 주요 임상 사건 예방 및 회복에 대한 다파글리플로진의 효과: DARE-19 연구의 설계 및 근거

Article

Published on 2021-04-012022-09-11
Journal: Diabetes, obesity & metabolism [Category] SARS, 임상,

[키워드] 1:1 acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Admission Adult patients all-cause mortality atherosclerotic benefit cardiometabolic cardiometabolic risk factor cardiovascular cardiovascular disease caused Chronic kidney disease clinical recovery clinical status clinical trial composite endpoint coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 COVID-19 complications COVID-19-related complication COVID-19-related complications Critically ill Dapagliflozin diabetes double-blind Effect Efficacy Eligible patients Endpoint evaluate event Glucose heart failure Hierarchical high-risk patient High-risk patients Hospitalization hypothese IMPROVE incidence individuals with COVID-19 inhibitor International investigator-initiated kidney Kidney disease Kidney injury material morbidity and mortality multicentre multiorgan failure organ organ dysfunction Patient patient population patients hospitalized patients with COVID-19 phase III study Placebo placebo-controlled study Prevent Randomized Randomized controlled trial randomized trial reduce respiratory complication Respiratory complications Respiratory failure Safety safety profile SGLT2 inhibitor shown sodium Treatment type 2 diabete type 2 diabetes with COVID-19 worsened
[DOI] 10.1111/dom.14296 PMC 바로가기 [Article Type] Article

Review of risk of COVID-19 in cancer patients and their cohabitants

암환자와 동거인의 코로나19 위험도 검토

Review

Published on 2021-04-012022-09-12
Journal: International Journal of Infectious Diseases [Category] MERS, SARS, 진단,

Anti-BCMA CAR T administration in a relapsed and refractory multiple myeloma patient after COVID-19 infection: a case report

COVID-19 감염 후 재발 및 불응성 다발성 골수종 환자에서 항BCMA CAR T 투여: 증례 보고

Case Reports

Published on 2021-02-192022-09-12
Journal: Journal of Medical Case Reports [Category] MERS, 진단,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 Administered administration Antigen antigen receptor antiviral antibodies antiviral antibody benefit Cancer patients CAR CAR T cell Case report Cell Cell therapy Chemotherapy chimeric antigen receptor clinical recovery clinical study Complete coronavirus coronavirus disease COVID-19 COVID-19 diagnosis COVID-19-related complications criteria CRS Cytokine release syndrome decision detectable dose Enrollment exacerbate global pandemic group Host immune immune response Immunosuppression infections initial male maturation Multiple myeloma Myeloma novel Novel coronavirus novel coronavirus disease pandemic Patient potential risk proceed receiving Registered risk SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 virus severe acute respiratory syndrome Coronavirus susceptible T cell the patient the SARS-CoV-2 virus therapy treated Treatment viral infection working
[DOI] 10.1186/s13256-020-02598-0 PMC 바로가기 [Article Type] Case Reports

A case series of children and young people admitted to a tertiary care hospital in Germany with COVID-19

Observational Study

Published on 2021-02-012022-10-04
Journal: BMC Infectious Diseases [Category] MERS, 임상,

Observational cohort study of IP-10’s potential as a biomarker to aid in inflammation regulation within a clinical decision support protocol for patients with severe COVID-19

심각한 COVID-19 환자를 위한 임상 의사 결정 지원 프로토콜 내에서 염증 조절을 돕는 바이오마커로서의 IP-10의 잠재력에 대한 관찰 코호트 연구

Clinical Trial

Published on 2021-01-122022-08-13
Journal: PLoS ONE [Category] Biochemistry, MERS, 바이오마커, 임상,

[키워드] acute respiratory syndrome acute respiratory syndrome coronavirus Admission Biomarker clinical decision cohort study coronavirus correlated Corticosteroid corticosteroid immunomodulatory therapy COVID-19 patient COVID-19 patients COVID-19-related complications died disease stage disease stages host protein host-pathogen interaction hyperinflammation immune immunoassay immunomodulatory therapy Inflammation intensive care intensive care unit interferon involved IP-10 Lung injury management Mortality Oxygenation Patient performed platform protocol quantitative measurement Registered Regulation respiratory Result severe acute respiratory syndrome Coronavirus severe acute respiratory syndrome coronavirus 2 severe COVID-19 severely ill COVID-19 patients Severity Score significantly single-center subsequent Support therapeutic utility Viral viral clearance virus-induced hyperinflammation while with COVID-19 γ-induced protein 10
[DOI] 10.1371/journal.pone.0245296 PMC 바로가기 [Article Type] Clinical Trial

Characteristics and Prognosis of COVID-19 in Patients with COPD

Article

Published on 2020-10-122022-10-30
Journal: Journal of Clinical Medicine [Category] COVID-19,

Changes in Dietary Behaviours during the COVID-19 Outbreak Confinement in the Spanish COVIDiet Study

Article

Published on 2020-06-102022-10-30
Journal: Nutrients [Category] COVID-19, SARS,